HIPEC combines the pharmacological advantage of moderatehyperthermia with intraperitoneal chemotherapy aiming to treatresidual disease following CCR-0/1 cytoreduction. Some investigators have shown a direct relationship between intraabdominal pressure (IAP) and convection-driven drug penetrationof macromolecular agents such as TNF-a into the tumor tissue